When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MOR - Xencor gets $25M milestone payment from MorphoSys
MorphoSys AG
The FDA approval of MorphoSys' Monjuvi, in a treatment in combination with lenalidomide for adult patients with relapsed or refractory diffuse large B cell lymphoma (DLBCL), has triggered a $25 million milestone payment and royalty on net sales for Xencor (NASDAQ:XNCR), the co. announced.
More news on: Xencor, Inc., MorphoSys AG, Incyte Corporation,